Esther Dyson

Esther Dyson is a longtime technology and healthcare investor, founder of Wellville, and a New York-based solo angel writing $25k-$100k checks at pre-seed, seed, and Series A in medical devices and digital health, with no AI flag. Her decades-long presence in healthcare investing, her Wellville public health initiative, and her network across health policy, public health, and population health give her a distinctive profile as a thoughtful, mission-driven angel with extraordinary network depth. Founders building digital health platforms with public health or population health angles, medical devices with broad social impact, or companies where her policy-and-population-health network adds meaningful value are the natural fit. She is the wrong audience for narrow B2B SaaS without a population health angle, biotech without a community-health link, or anything that doesn’t connect to her broader Wellville-style mission orientation. The small check size positions her as a high-signal mission-aligned angel rather than a meaningful capital source, but her network access in policy, public health, and population health is hard to replicate. Outreach via LinkedIn or Twitter (@edyson) is viable given her active public posture, and tight, mission-aligned, substantive notes outperform generic pitch decks. Warm introductions through Wellville, the broader public health investor community, or fellow long-time digital health investors materially help. Best treated as a network-and-mission specialist angel.